• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Mechanical Circulator Support Device Market

    ID: MRFR/HC/31665-HCR
    128 Pages
    Rahul Gotadki
    September 2025

    Mechanical Circulator Support Device Market Research Report By Type (Intra-Aortic Balloon Pump, Ventricular Assist Device, Total Artificial Heart, Extracorporeal Membrane Oxygenation), By Application (Cardiac Surgery, Heart Failure Management, Myocardial Infarction, Cardiogenic Shock), By End Use (Hospitals, Ambulatory Surgical Centers, Home Care), By Mode of Operation (Implantable Devices, Extracorporeal Devices) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Forecast to 2034

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Mechanical Circulator Support Device Market Research Report — Global Forecast till 2034 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Mechanical Circulator Support Device Market Summary

    The Global Mechanical Circulator Support Device Market is projected to grow significantly from 3.8 USD Billion in 2024 to 8.84 USD Billion by 2035.

    Key Market Trends & Highlights

    Mechanical Circulator Support Device Key Trends and Highlights

    • The market is anticipated to expand at a compound annual growth rate (CAGR) of 7.98% from 2025 to 2035.
    • By 2035, the market valuation is expected to reach 8.84 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 3.8 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of mechanical circulator support devices due to increasing prevalence of heart diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 3.8 (USD Billion)
    2035 Market Size 8.84 (USD Billion)
    CAGR (2025-2035) 7.98%

    Major Players

    Cleveland Heart, Boston Scientific, Tandem Diabetes, HeartWare International, Medtronic, Abbott Laboratories, Getinge AB, Terumo Corporation, NeuroTrac, Fresenius SE and KGaA, Nordion, Jude Medical, Abiomed, SynCardia Systems, CardioGenics

    Mechanical Circulator Support Device Market Trends

    The Mechanical Circulator Support Device Market is experiencing significant growth driven by factors such as the rising prevalence of heart diseases and the increasing aging population. As the number of patients requiring cardiac support rises, there is a growing demand for advanced circulatory support devices that can provide effective treatment options in critical situations. Additionally, technological advancements in medical devices are enhancing their efficiency and functionality, leading to greater adoption by healthcare providers.

    This shift towards better patient outcomes and improved surgical procedures is a key market driver, making mechanical circulatory support devices more appealing in various clinical settings.Numerous opportunities exist for stakeholders to explore within this market. 

    Innovations in device design and materials are creating pathways to develop more compact, user-friendly, and biocompatible devices, which can vastly improve patient care. There is also potential for market players to expand their geographic reach, especially in emerging economies where the healthcare infrastructure is evolving. Increased investment in research and development can foster the creation of next-generation devices that deliver enhanced performance and safety, thus capturing a larger share of the market. Recent trends underscore the integration of artificial intelligence and telemedicine with mechanical circulatory support devices, enabling better monitoring and remote patient management.

    This technology adoption reflects a broader shift towards personalized medicine, whereby treatments are tailored to individual patient needs, improving overall outcomes. As healthcare systems seek to enhance patient care while managing costs, the demand for innovative circulatory support solutions is likely to rise, further driving growth in the market. The emphasis on minimally invasive procedures and better patient compliance continues to shape the direction of this industry, pointing towards a more efficient and responsive healthcare landscape.

    The increasing prevalence of heart failure and advancements in technology are driving the adoption of mechanical circulatory support devices, which are poised to transform patient care in cardiovascular medicine.

    U.S. Food and Drug Administration (FDA)

    Mechanical Circulator Support Device Market Drivers

    Market Growth Projections

    The Global Mechanical Circulator Support Device Market Industry is poised for substantial growth, with projections indicating a market value of 3.8 USD Billion in 2024 and an anticipated increase to 8.84 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 7.98% from 2025 to 2035, reflecting the increasing demand for mechanical circulatory support devices driven by various factors, including technological advancements and rising cardiovascular disease prevalence.

    Increasing Geriatric Population

    The aging population is a significant driver of the Global Mechanical Circulator Support Device Market Industry. As the global demographic shifts towards an older population, the incidence of age-related cardiovascular diseases rises correspondingly. This demographic trend necessitates the adoption of mechanical circulatory support devices to manage heart failure and other related conditions effectively. The growing geriatric population is expected to propel the market forward, as healthcare systems adapt to meet the needs of older patients requiring advanced cardiac support.

    Technological Advancements in Device Design

    Technological innovations play a pivotal role in shaping the Global Mechanical Circulator Support Device Market Industry. Recent advancements in device design, such as miniaturization and improved biocompatibility, enhance the effectiveness and safety of these devices. For example, the development of next-generation ventricular assist devices has led to better patient experiences and outcomes. These innovations are likely to contribute to a market growth trajectory that could reach 8.84 USD Billion by 2035, reflecting a compound annual growth rate of 7.98% from 2025 to 2035.

    Rising Prevalence of Cardiovascular Diseases

    The Global Mechanical Circulator Support Device Market Industry is experiencing growth driven by the increasing prevalence of cardiovascular diseases. As heart conditions continue to rise globally, the demand for advanced treatment options, including mechanical circulatory support devices, escalates. For instance, heart failure affects millions worldwide, leading to a projected market value of 3.8 USD Billion in 2024. This trend indicates a pressing need for innovative solutions that can enhance patient outcomes and reduce mortality rates associated with heart diseases.

    Government Initiatives and Funding for Cardiac Care

    Government initiatives and funding aimed at improving cardiac care significantly influence the Global Mechanical Circulator Support Device Market Industry. Various health authorities are investing in research and development to enhance treatment options for cardiovascular diseases. These initiatives often include grants and subsidies for innovative medical technologies, which can accelerate the adoption of mechanical circulatory support devices. Such support not only fosters innovation but also ensures that healthcare providers have access to the latest advancements, ultimately benefiting patients with heart conditions.

    Rising Awareness and Acceptance of Advanced Therapies

    There is a growing awareness and acceptance of advanced therapies within the Global Mechanical Circulator Support Device Market Industry. Patients and healthcare providers are increasingly recognizing the benefits of mechanical circulatory support devices as viable treatment options for severe heart failure. Educational initiatives and advocacy efforts contribute to this trend, fostering a more informed patient population. As acceptance increases, the demand for these devices is likely to rise, further driving market growth and encouraging manufacturers to innovate and expand their product offerings.

    Market Segment Insights

    Mechanical Circulator Support Device Market Type Insights

    The Mechanical Circulator Support Device Market has shown substantial growth, with several types contributing significantly to this expansion. In 2023, the overall market value was estimated at 3.26 USD Billion, reflecting a robust demand for these medical devices.

    Among the various types, the Intra-Aortic Balloon Pump is valued at 0.8 USD Billion in the same year, showcasing its critical role in augmenting coronary perfusion during high-risk surgeries and managing heart failure. With its projected increase to 1.6 USD Billion by 2032, this type plays a crucial role, particularly in emergency and critical care settings, thus asserting its importance in the overall market.The Ventricular Assist Device holds a significant share, valued at 1.5 USD Billion in 2023 and anticipated to expand to 3.0 USD Billion by 2032. 

    This device is essential for patients with severe heart failure, allowing them to maintain quality of life while awaiting heart transplants or as a long-term therapy option. Its major growth reflects the increasing prevalence of heart diseases and advancements in technology, enhancing patient outcomes.

    Meanwhile, the Total Artificial Heart, with a valuation of 0.4 USD Billion in 2023 and expected to double to 0.8 USD Billion by 2032, plays a vital role, albeit with a smaller market share.This device is primarily utilized in patients with terminal heart failure who are not candidates for transplant, thereby representing a significant but niche segment of the market.

    Lastly, Extracorporeal Membrane Oxygenation is valued at 0.56 USD Billion in 2023 and is projected to rise to 1.1 USD Billion by 2032, indicating rising importance in severe cardiac and respiratory failure cases. This method has become vital in critical care units, illustrating a growing trend towards advanced life support technologies. Each type within the Mechanical Circulator Support Device Market segmentation plays a unique role in addressing heart-related health issues, demonstrating both significant current valuations and growth potential, thereby contributing to the overall market landscape.

    Mechanical Circulator Support Device Market Application Insights

    The Mechanical Circulator Support Device Market, valued at 3.26 USD Billion in 2023, showcases significant growth potential driven by diverse applications in the healthcare sector. This market is characterized by its wide range of applications, including cardiac surgery, heart failure management, myocardial infarction, and cardiogenic shock, each playing a crucial role in patient care and recovery. Cardiac surgery remains a vital segment, reflecting the demand for advanced support devices during surgical procedures, while heart failure management necessitates innovative solutions to improve patient outcomes.

    Myocardial infarction and cardiogenic shock are critical conditions where mechanical support devices provide life-saving assistance, making these applications pivotal for healthcare advancements. The market growth is further fueled by rising incidences of cardiovascular diseases, a growing aging population, and increased investment in medical technology. However, challenges such as high costs and regulatory hurdles could impact market expansion.

    Despite this, the ongoing development of more efficient and reliable devices promises ample opportunities within the Mechanical Circulator Support Device Market industry.As a result, the segmentation of applications highlights the diverse needs within the sector, emphasizing the importance of tailored solutions for different critical conditions.

    Mechanical Circulator Support Device Market End-Use Insights

    The Mechanical Circulator Support Device Market is poised for significant growth, particularly within its End-use segment. Hospitals represent a primary domain for these devices, where critical care and advanced surgeries often necessitate mechanical circulatory support for patients with severe heart conditions. Ambulatory Surgical Centers are also becoming increasingly vital, providing specialized, less invasive procedures that benefit greatly from the efficiency of mechanical support systems. Home Care is emerging as an important area as well, with a rising number of patients seeking recovery and rehabilitation in more comfortable settings outside traditional healthcare facilities.

    This trend is driven by the convenience of at-home care and technology advancements, which allow for effective monitoring and support of patients. The overall Mechanical Circulator Support Device Market revenue is expected to be valued at 3.26 billion USD in 2023, emphasizing the significant role that these end-use applications play in driving market growth. Mechanical Circulator Support Device Market data indicates a dynamic landscape where hospitals, ambulatory centers, and home care facilities contribute to the diverse Mechanical Circulator Support Device Market segmentation, reflecting ongoing innovations and a focus on patient-centered care across the Mechanical Circulator Support Device Market industry.

    Mechanical Circulator Support Device Market Mode of Operation Insights  

    The Mechanical Circulator Support Device Market is expanding steadily, with a valuation of 3.26 USD billion in 2023 and projected growth to 6.5 USD billion by 2032. Within the mode of operation segment, the market encompasses both implantable devices and extracorporeal devices, each playing a critical role in patient care. Implantable port have become a cornerstone of therapy for patients requiring long-term support, fostering improved patient outcomes and encouraging greater investment in research and development. 

    Meanwhile, extracorporeal devices dominate in acute settings, offering rapid deployment and effective support for patients in critical care.The ongoing innovation within these categories continues to create new opportunities, enabling better management of heart dysfunctions while addressing the complexities involved in device implantation and patient monitoring. As healthcare providers seek to optimize treatment protocols, the Mechanical Circulator Support Device Market is poised to experience significant advancements alongside rising healthcare demand and evolving patient needs.

    Get more detailed insights about Mechanical Circulator Support Device Market Research Report — Global Forecast till 2034

    Regional Insights

    The Mechanical Circulator Support Device Market is experiencing significant growth, with North America leading the charge, holding a valuation of 1.224 USD Billion in 2023, reflecting its dominant position due to advanced healthcare infrastructure and high patient demand. Europe follows closely, valued at 0.765 USD Billion, supported by strong healthcare investments and technological advancements. The APAC region, while currently at 0.612 USD Billion, is poised for notable expansion, driven by rising healthcare access and increasing awareness of cardiac therapies.

    South America, with a valuation of 0.306 USD Billion, presents growth opportunities through improvements in medical technologies and an expanding patient base. Meanwhile, the MEA region, valued at 0.352 USD Billion, is emerging gradually, with a focus on enhancing healthcare services. Each of these regions contributes to the Mechanical Circulator Support Device Market revenue, showcasing diverse growth dynamics and opportunities across different economies. The majority holding in North America underscores its significance in setting industry standards and innovations, while the emerging markets in APAC and MEA signify the potential for future expansion in the Mechanical Circulator Support Device Market statistics.

    Mechanical Circulator Support Device Market by North America

    Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    Competitive insights reveal a landscape where not only established players hold significant market shares but also emerging companies are making their mark with innovative solutions. Strategic collaborations, mergers and acquisitions, as well as ongoing research and development activities, are essential to enhance product portfolios and expand market reach. Companies are focusing on regulatory approvals and building a strong distribution network to cater to the changing needs of healthcare providers and patients.

    This competitive environment fosters a dynamic atmosphere where technological advancements are pivotal in shaping the future of mechanical circulator support devices.Cleveland Heart stands out within the Mechanical Circulator Support Device Market due to its commitment to innovation and quality in developing heart support technologies. 

    The company has a strong reputation for producing devices that provide reliable and effective support to patients suffering from severe cardiac conditions. Their solutions are tailored towards enhancing surgical outcomes, thus ensuring improved patient recovery timelines. Cleveland Heart's continuous investment in research and development has resulted in cutting-edge devices that are not only clinically relevant but also aligned with the latest healthcare trends. Moreover, their established relationships with healthcare consumers and providers facilitate a robust distribution network, giving them a significant advantage in the marketplace.

    The company's commitment to safety and efficacy in its product offerings reinforces its market position and fosters trust among healthcare professionals.

    Boston Scientific has established a firm footing in the Mechanical Circulator Support Device Market through its strategic approach to developing advanced medical technologies aimed at treating cardiovascular diseases. The company is recognized for its extensive product range that includes various mechanical circulatory support devices designed to improve patient outcomes. Boston Scientific emphasizes innovation through rigorous research initiatives, resulting in state-of-the-art solutions that not only meet regulatory standards but also address the evolving needs of clinicians and patients. Its well-structured marketing and distribution strategies enable Boston Scientific to maintain a competitive edge by reaching diverse geographical markets. 

    The company's focus on collaboration with healthcare professionals ensures that its products are both clinically relevant and practical, thereby driving adoption rates and enhancing its influence in the mechanical circulatory support landscape.

    Key Companies in the Mechanical Circulator Support Device Market market include

    Industry Developments

    • Q2 2024: CorWave receives CE Mark approval for its left ventricular assist device CorWave announced it has received CE Mark approval for its left ventricular assist device, enabling commercial launch in the European Union.
    • Q2 2024: Abiomed launches Impella ECP, the world’s smallest heart pump, in Europe Abiomed announced the commercial launch of its Impella ECP, a next-generation expandable heart pump, in select European markets following regulatory clearance.
    • Q1 2024: BiVACOR secures $18 million Series B funding to advance artificial heart development BiVACOR raised $18 million in Series B funding to support clinical trials and further development of its total artificial heart technology.
    • Q2 2024: Medtronic receives FDA approval for HeartWare HVAD System for destination therapy Medtronic announced FDA approval for its HeartWare HVAD System as a destination therapy for patients with advanced heart failure.
    • Q1 2025: Procyrion raises $30 million Series C to expand mechanical circulatory support device trials Procyrion closed a $30 million Series C funding round to accelerate clinical trials and commercialization of its mechanical circulatory support device.
    • Q2 2025: Abbott announces partnership with Cleveland Clinic to advance cardiac support device research Abbott entered a strategic partnership with Cleveland Clinic to collaborate on research and development of next-generation mechanical circulatory support devices.
    • Q2 2024: FDA grants Breakthrough Device designation to Evaheart’s next-generation ventricular assist device Evaheart received Breakthrough Device designation from the FDA for its new ventricular assist device, expediting regulatory review and development.
    • Q3 2024: Windmill Cardiovascular Systems opens new manufacturing facility in Texas Windmill Cardiovascular Systems inaugurated a new manufacturing facility in Texas to scale up production of its mechanical circulatory support devices.
    • Q1 2025: SynCardia Systems appoints new CEO to lead global expansion SynCardia Systems announced the appointment of a new CEO to drive international growth and commercialization of its total artificial heart products.
    • Q2 2025: NuPulseCV receives FDA IDE approval for clinical trial of intravascular ventricular assist system NuPulseCV received FDA Investigational Device Exemption (IDE) approval to begin clinical trials of its intravascular ventricular assist system in the United States.
    • Q1 2024: Abbott launches new HeartMate 3 LVAD in Japan following regulatory approval Abbott announced the launch of its HeartMate 3 left ventricular assist device in Japan after receiving regulatory approval from Japanese authorities.
    • Q3 2024: Evaheart partners with Mayo Clinic for clinical research on advanced heart failure therapies Evaheart entered a partnership with Mayo Clinic to conduct clinical research on its mechanical circulatory support devices for advanced heart failure patients.

    Future Outlook

    Mechanical Circulator Support Device Market Future Outlook

    The Mechanical Circulator Support Device Market is projected to grow at a 7.98% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising geriatric population.

    New opportunities lie in:

    • Develop next-generation devices with AI integration for enhanced patient monitoring.
    • Expand into emerging markets with tailored solutions for local healthcare needs.
    • Invest in partnerships with hospitals for integrated circulatory support programs.

    By 2035, the market is expected to achieve substantial growth, reflecting advancements and increased adoption of circulatory support technologies.

    Market Segmentation

    Mechanical Circulator Support Device Market Type Outlook

    • Intra-Aortic Balloon Pump
    • Ventricular Assist Device
    • Total Artificial Heart
    • Extracorporeal Membrane Oxygenation

    Mechanical Circulator Support Device Market End-Use Outlook

    • Hospitals
    • Ambulatory Surgical Centers
    • Home Care

    Mechanical Circulator Support Device Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia-Pacific
    • Middle East and Africa

    Mechanical Circulator Support Device Market Application Outlook

    • Cardiac Surgery
    • Heart Failure Management
    • Myocardial Infarction
    • Cardiogenic Shock

    Mechanical Circulator Support Device Market Mode of Operation Outlook

    • Implantable Devices
    • Extracorporeal Devices

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024    3.80 (USD Billion)
    Market Size 2025    4.10 (USD Billion)
    Market Size 2034    8.19 (USD Billion)
    Compound Annual Growth Rate (CAGR)    7.97 % (2025 - 2034)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2034
    Historical Data 2020 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled Cleveland Heart, Boston Scientific, Tandem Diabetes, HeartWare International, Medtronic, Abbott Laboratories, Getinge AB, Terumo Corporation, NeuroTrac, Fresenius SE  and  Co. KGaA, Nordion, St. Jude Medical, Abiomed, SynCardia Systems, CardioGenics
    Segments Covered Type, Application, End Use, Mode of Operation, Regional
    Key Market Opportunities Growing heart failure prevalence, Advancements in device technology, Increasing aging population, Rising demand for minimally invasive procedures, Expanding healthcare infrastructure in emerging markets
    Key Market Dynamics Aging population, Technological advancements, Rising cardiovascular diseases, Increasing healthcare expenditure, Regulatory approvals and compliance
    Countries Covered North America, Europe, APAC, South America, MEA

    FAQs

    What is the expected market size of the Mechanical Circulator Support Device Market by 2034?

    The Mechanical Circulator Support Device Market is expected to be valued at 8.19 USD Billion by 2034.

    What is the projected CAGR of the Mechanical Circulator Support Device Market from 2025 to 2034?

    The expected CAGR for the Mechanical Circulator Support Device Market from 2025 to 2034 is 7.97%.

    Which region holds the largest market share in the Mechanical Circulator Support Device Market?

    North America holds the largest market share, valued at 1.224 USD Billion in 2023.

    What are the market values for the Ventricular Assist Device segment in 2032?

    The Ventricular Assist Device segment is expected to reach a market value of 3.0 USD Billion in 2032.

    Who are the major players in the Mechanical Circulator Support Device Market?

    Key players include Cleveland Heart, Boston Scientific, Tandem Diabetes, and Medtronic, among others.

    What is the market size for the Intra-Aortic Balloon Pump segment by 2032?

    The Intra-Aortic Balloon Pump segment is expected to be valued at 1.6 USD Billion by 2032.

    How is the Mechanical Circulator Support Device Market expected to grow in the APAC region by 2032?

    The APAC region is projected to grow to a market value of 1.33 USD Billion by 2032.

    What is the expected growth for Extracorporeal Membrane Oxygenation from 2023 to 2032?

    The Extracorporeal Membrane Oxygenation segment is expected to grow from 0.56 USD Billion in 2023 to 1.1 USD Billion by 2032.

    Which segment is anticipated to show significant growth within the Mechanical Circulator Support Device Market?

    The Ventricular Assist Device segment is anticipated to show significant growth in the coming years.

    What are the projected market values for South America and MEA by 2032?

    South America is expected to reach 0.591 USD Billion, and MEA is projected to reach 0.739 USD Billion by 2032.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials